Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment

As part of the Strafford Publications’ webinar series, Finnegan attorneys Mark Feldstein, Alissa Lipton, Amanda Murphy, William Raich, and Yieyie Yang will discuss the Biologics Price Competition and Innovation Act (BPCIA). They will address the ongoing debate over whether the BPCIA's patent dispute resolution procedures are allowed or required, and the litigation that has followed. They will also review the case law from 12 years of the BPCIA and discuss where things are headed. For more information, or to register, please see Strafford’s website.